MyAverix Finance
NS · Pharmaceuticals
Piramal Pharma Ltd (PPLPHARMA)
Pharmaceuticals & Biotechnology
Piramal Pharma Ltd (PPLPHARMA) is listed on NS in the Pharmaceuticals sector. Industry: Pharmaceuticals & Biotechnology. As of 2026-07-10, reported market cap is $224.71B, P/E ratio is 32.08, net margin is 11.3%, dividend yield is 0.08%. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.
Key metrics for PPLPHARMA
Piramal Pharma Ltd (PPLPHARMA) — FAQ
What is Piramal Pharma Ltd's market cap?
Piramal Pharma Ltd (PPLPHARMA) has a reported market cap of $224.71B (data as of 2026-07-10).
What is PPLPHARMA's P/E ratio?
The price-to-earnings (P/E) ratio for Piramal Pharma Ltd (PPLPHARMA) is 32.08 (data as of 2026-07-10).
Does Piramal Pharma Ltd pay a dividend?
Piramal Pharma Ltd (PPLPHARMA) shows a reported dividend yield of 0.08%. Open the MyAverix Finance app for dividend history and payout details (data as of 2026-07-10).
What sector is Piramal Pharma Ltd in?
Piramal Pharma Ltd (PPLPHARMA) is classified in the Pharmaceuticals sector (Pharmaceuticals & Biotechnology industry).
What exchange is PPLPHARMA listed on?
PPLPHARMA is listed on NS.
What is Piramal Pharma Ltd's net margin?
Piramal Pharma Ltd (PPLPHARMA) reports a net margin of 11.3% (data as of 2026-07-10).
Full report in the app
Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.